Assess the person's stroke risk using the CHA2DS2-VASc score, and their bleeding risk using the ORBIT bleeding risk score if considering anticoagulation, managing modifiable risk factors for bleeding such as uncontrolled hypertension, frailty, and falls risk where possible NICE CKS.
Do not withhold anticoagulation solely based on falls risk, as falls are rarely a cause of major haemorrhage, and the benefits of stroke prevention generally outweigh the bleeding risk NICE CKS.
Offer anticoagulation with a direct-acting oral anticoagulant (DOAC) first-line if indicated, considering individual risk profiles and preferences, and ensure appropriate dose and management of bleeding risk factors NICE CKS.
If a DOAC is contraindicated or not tolerated, consider warfarin with careful INR monitoring, but do not exclude anticoagulation solely due to falls risk NICE CKS.